Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07211555 · ClinicalTrials.gov registry record · NA
The LARC Robot Simplifies Renal Access In Percutaneous Nephrolithotomy
A NA study, sponsored by AdventHealth.
- Not yet
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07211555 is a NA study that has not yet begun recruiting, run by AdventHealth. The registered enrollment target is 45 participants.
The verdict
NCT07211555, a NA study, has not yet begun recruiting, sponsored by AdventHealth.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study is being done to evaluate a new robotic system that helps urologists more precisely reach the kidney during surgery to remove large kidney stones. The procedure, called percutaneous nephrolithotomy (PCNL), is typically used for people who have large or difficult-to-remove kidney stones. Traditionally, many urologists rely on radiologists to place a tube into the kidney before surgery. This can cause delays, require multiple procedures, and increase costs. The robotic system being studied - called LARC - is designed to help the urologist safely and accurately guide a needle directly into the kidney during the surgery, without needing a separate procedure beforehand. The robot uses live X-ray images to help align the instruments. Although parts of the robot have been approved by the U.S. FDA, the version used in this study is still investigational and not yet approved for this specific purpose. The study will take place at AdventHealth Celebration and include up to 45 adult patients who are scheduled for PCNL surgery. Participants will be followed for up to 1 month after surgery, and doctors will look at outcomes such as the success of the procedure, the number of kidney stones removed, complications, time in surgery, and radiation exposure. This research may help make kidney stone surgery safer, faster, and more effective in the future.
Interventions
- DEVICE LARC Robotic System (Micromate™ Version 3.0)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2026-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07211555
The ClinicalTrials.gov registry entry for NCT07211555 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LARC Robotic System (Micromate™ Version 3.0) is the first listed.
NCT07211555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07211555 about?
NCT07211555 is a clinical study titled "The LARC Robot Simplifies Renal Access In Percutaneous Nephrolithotomy". This study is being done to evaluate a new robotic system that helps urologists more precisely reach the kidney during surgery to remove large kidney stones. The procedure, called percutaneous nephrolithotomy (PCNL), is typically used for people who have large or difficult-to-remove kidney stones. ...
What is the current status of trial NCT07211555?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-11-01. Estimated completion is 2026-01-01.
What interventions are being tested in trial NCT07211555?
The interventions under investigation include: LARC Robotic System (Micromate™ Version 3.0) (DEVICE).
Who is sponsoring clinical trial NCT07211555?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.